399.20

0.23% 0.91

West Pharmaceutical Services Inc (WST)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$398.29

Aprire:

$396.95

Volume 24 ore:

122.65K

Relative Volume:

0.22

Capitalizzazione di mercato:

$28.09B

Reddito:

$3.22B

Utile/perdita netta:

$542.70M

Rapporto P/E:

53.37

EPS:

7.4805

Flusso di cassa netto:

$458.00M

1 W Prestazione:

+1.45%

1M Prestazione:

+6.27%

6M Prestazione:

+36.65%

1 anno Prestazione:

+40.82%

Intervallo 1D:

$396.83

$402.50

Intervallo di 1 settimana:

$388.06

$398.67

Portata 52W:

$223.83

$402.50

West Pharmaceutical Services Inc Stock (WST) Company Profile

Nome

West Pharmaceutical Services Inc

Settore

Healthcare (1053)

Industria

Medical Instruments & Supplies (51)

Telefono

(610) 594-2900

Indirizzo

530 HERMAN O. WEST DRIVE, EXTON, PA

Dipendente

10,800

Cinguettio

@WestPharma

Prossima data di guadagno

2026-10-29

Ultimi documenti SEC

WST's Discussions on Twitter

Compare WST vs ISRG, BDX, RMD, ALC, MDLN

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WST West Pharmaceutical Services Inc	399.20	28.09B	3.22B	542.70M	458.00M	7.4805
ISRG Intuitive Surgical Inc	447.66	158.15B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	194.84	53.07B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	251.16	35.32B	5.54B	1.52B	1.74B	10.37
ALC Alcon Inc	69.57	33.63B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	32.67	28.66B	29.14B	1.07B	1.05B	1.1956

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-09-22	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2026-09-09	Ripresa	UBS	Buy
2026-07-13	Iniziato	BNP Paribas Exane	Outperform
2026-06-09	Aggiornamento	Barclays	Equal Weight → Overweight
2026-06-02	Ripresa	Wolfe Research	Outperform
2025-12-02	Iniziato	Morgan Stanley	Equal-Weight
2025-09-15	Iniziato	Rothschild & Co Redburn	Buy
2025-06-24	Iniziato	Barclays	Equal Weight
2025-03-18	Iniziato	Evercore ISI	Outperform
2025-02-14	Aggiornamento	Deutsche Bank	Hold → Buy
2025-01-08	Iniziato	Citigroup	Buy
2024-12-13	Iniziato	Wolfe Research	Peer Perform
2024-12-12	Aggiornamento	UBS	Neutral → Buy
2024-02-07	Aggiornamento	Jefferies	Hold → Buy
2023-06-16	Aggiornamento	BofA Securities	Neutral → Buy
2023-04-11	Aggiornamento	Stephens	Equal-Weight → Overweight
2022-12-14	Iniziato	Deutsche Bank	Hold
2022-11-30	Iniziato	UBS	Neutral
2022-10-28	Downgrade	BofA Securities	Buy → Neutral
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-10-14	Iniziato	Stephens	Equal-Weight
2020-07-21	Aggiornamento	BofA Securities	Neutral → Buy
2020-04-24	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-12-12	Downgrade	BofA/Merrill	Neutral → Underperform
2019-07-26	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-05-01	Downgrade	Jefferies	Buy → Hold
2019-04-23	Iniziato	William Blair	Outperform
2018-04-25	Downgrade	BofA/Merrill	Neutral → Underperform
2018-01-24	Iniziato	Goldman	Neutral
2017-10-17	Downgrade	BofA/Merrill	Buy → Neutral
2017-10-03	Iniziato	Stephens	Equal-Weight
2017-09-15	Aggiornamento	Jefferies	Hold → Buy
2016-10-28	Aggiornamento	Wells Fargo	Market Perform → Outperform
2016-09-21	Downgrade	Wells Fargo	Outperform → Market Perform
2016-03-22	Iniziato	Wells Fargo	Outperform
2010-05-14	Reiterato	UBS	Neutral
2010-02-23	Iniziato	Jefferies & Co	Buy
2008-12-19	Iniziato	UBS	Neutral

Mostra tutto

West Pharmaceutical Services Inc Borsa (WST) Ultime notizie

Oct 27, 2026

West Pharmaceutical Services earnings: what to look for from WST - FinancialContent

Oct 27, 2026

West Pharmaceutical Services Enhances Liquidity With New Credit Facility - The Globe and Mail

Oct 27, 2026